Dr. Sebastian Schloer

Further involvements

• 28/03/2023

  • Poster
  • P 234

  The host-targeted MEK1/2-inhibitor ATR-002 (Zapnometinib) acts antiviral against SARS-CoV-2 and synergistically potentiates the antiviral effect of direct-acting anti-SARS-CoV-2 drugs

   Host cell factors and modulation, SARS-CoV-2
• 28/03/2023

  • Poster
  • P 109

  Antiviral drug repurposing – pharmacologically induced endolysosomal cholesterol imbalance impairs replication of human pathogenic Ebola viruses in vitro

   Emerging viruses and zoonosis
• 28/03/2023

  16:45 – 17:00 12 Min. 3 Min.

  • Abstract Talk
  • O 005

  Setting up the "Endolysosomal Firewall" – endolysosomal cholesterol balance as an antiviral barrier for enveloped virus infection

   Virus receptors and entry